Alimentiv Inc. Sustainability Profile
Alimentiv Inc., a leading name in the clinical research industry, is headquartered in California and operates across North America and Europe. Founded in 2018, the company has quickly established itself as a trusted partner in the development of innovative therapies, particularly in the fields of gastroenterology and inflammatory bowel disease. Alimentiv's core services include clinical trial management, regulatory consulting, and data analytics, all tailored to meet the unique needs of its clients. What sets Alimentiv apart is its commitment to patient-centric research and its extensive expertise in complex clinical trials. With a strong market position, Alimentiv has achieved notable milestones, including successful collaborations with major pharmaceutical companies, reinforcing its reputation as a reliable and knowledgeable partner in the biopharmaceutical landscape.
DitchCarbon Score
How does Alimentiv Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alimentiv Inc.'s score of 29 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alimentiv Inc.'s reported carbon emissions
In 2024, Alimentiv Inc. reported total carbon emissions of approximately 2,065,000 kg CO2e. This figure includes 97,000 kg CO2e from Scope 1 emissions, 132,000 kg CO2e from Scope 2 emissions, and a significant 1,836,000 kg CO2e from Scope 3 emissions. Alimentiv has committed to near-term emissions reduction targets, although specific numerical targets have not been disclosed. The company has not yet committed to a net-zero target. Their climate commitments are aligned with industry standards, reflecting a proactive approach to managing their carbon footprint within the pharmaceuticals, biotechnology, and life sciences sector. The emissions data is not cascaded from any parent organization, indicating that these figures are solely representative of Alimentiv Inc.'s own operations. The company continues to focus on sustainability and reducing its environmental impact as part of its corporate responsibility initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 97,000 |
| Scope 2 | 132,000 |
| Scope 3 | 1,836,000 |
How Carbon Intensive is Alimentiv Inc.'s Industry?
How Carbon Intensive is Alimentiv Inc.'s Location?
Alimentiv Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alimentiv Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Syneos Health
Boehringer Ingelheim Pharmaceuticals, Inc.
Frequently Asked Questions
Common questions about Alimentiv Inc.'s sustainability data and climate commitments